FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apotex Paroxetine Hydrochloride Tablets Recall

Paroxetine Hydrochloride Tablets USP, RX only, 20 mg, a) 100-count bottle

Apotex Corp. · Weston, FL

Risk level
Class II
Reported by FDA
Dec 6, 2023
Recall ID
D-0120-2024
Check your lot numberHow we source this data

Summary

Apotex recalled Paroxetine Hydrochloride Tablets starting Nov 1, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0120-2024 on Dec 6, 2023. Reason: Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Product description

Paroxetine Hydrochloride Tablets USP, RX only, 20 mg, a) 100-count bottle, NDC#:60505-0083-2; b) 1000-count bottle, NDC#: 60505-0083-4 Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.

Lot numbers, UPCs & expiration codes

Lot numbers: a)100 count bottle: RV2384, RV2385; b) 1000 count bottle: RV2396, RV2397; Exp. 08/2024

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0120-2024
Classification
Class II
Status
Ongoing
Recall initiated
Nov 1, 2023
FDA report date
Dec 6, 2023
Quantity
48,623
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-0120-2024, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Ongoing
Country
United States
Event ID
93353
Address
2400 N Commerce Pkwy Ste 400
Code information
Lot numbers: a)100 count bottle: RV2384, RV2385; b) 1000 count bottle: RV2396, RV2397; Exp. 08/2024
Postal code
33326-3253
Report date
Dec 6, 2023
Product type
Drugs
Recall number
D-0120-2024
Classification
Class II
Recalling firm
Apotex Corp.
Product quantity
48,623
Reason for recall
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Voluntary / mandated
Voluntary: Firm initiated
Product description
Paroxetine Hydrochloride Tablets USP, RX only, 20 mg, a) 100-count bottle, NDC#:60505-0083-2; b) 1000-count bottle, NDC#: 60505-0083-4 Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.
Distribution pattern
Nationwide
Recall initiation date
Nov 1, 2023
Initial firm notification
E-Mail
Center classification date
Nov 27, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0120-2024, published Dec 6, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls